Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

950 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study.
Russell MD, Yang Z, Dooley N, Gibson M, Zuckerman B, Adas MA, Alveyn E, Patel S, Bechman K, Price E, Gallagher S, Coalwood C, Cope AP, Norton S, Galloway JB. Russell MD, et al. Among authors: galloway jb. Rheumatology (Oxford). 2024 Nov 1:keae607. doi: 10.1093/rheumatology/keae607. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39485485
Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY study.
Wasehuus V, Rotbain Curovic V, Tofte N, Lindhardt M, Currie G, Delles C, Frimodt-Møller M, Mischak H, von der Leyen H, Hansen TW, Kümler T, Persson F, Rossing P; PRIORITY Study group. Wasehuus V, et al. Diabetes Obes Metab. 2025 Jan;27(1):387-393. doi: 10.1111/dom.16037. Epub 2024 Oct 28. Diabetes Obes Metab. 2025. PMID: 39468380 Clinical Trial.
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study.
Russell MD, Gibson M, Zuckerman B, Kumar K, Dubey S, Adas MA, Alveyn E, Patel S, Yang Z, Bechman K, Price E, Gallagher S, Cope AP, Norton S, Galloway JB. Russell MD, et al. Among authors: galloway jb. Lancet Rheumatol. 2025 Jan;7(1):e44-e54. doi: 10.1016/S2665-9913(24)00221-2. Epub 2024 Oct 16. Lancet Rheumatol. 2025. PMID: 39423845 Free article.
950 results